Literature DB >> 1954775

Gene transfer as an approach to cure patients with hemophilia A or B.

A R Thompson1, T D Palmer, C M Lynch, A D Miller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1954775     DOI： 10.1159/000419338

Source DB:  PubMed          Journal:  Curr Stud Hematol Blood Transfus        ISSN： 0258-0330


× No keyword cloud information.
  2 in total

1.  The human clotting factor VIII cDNA contains an autonomously replicating sequence consensus- and matrix attachment region-like sequence that binds a nuclear factor, represses heterologous gene expression, and mediates the transcriptional effects of sodium butyrate.

Authors:  F J Fallaux; R C Hoeben; S J Cramer; D J van den Wollenberg; E Briët; H van Ormondt; A J van Der Eb
Journal:  Mol Cell Biol       Date:  1996-08       Impact factor: 4.272

2.  In vivo hepatic gene therapy: complete albeit transient correction of factor IX deficiency in hemophilia B dogs.

Authors:  M A Kay; C N Landen; S R Rothenberg; L A Taylor; F Leland; S Wiehle; B Fang; D Bellinger; M Finegold; A R Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.